Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks

被引：0
|
作者：
Blauvelt, Andrew [1 ]
de Bruin-Weller, Marjolein [2 ]
Gooderham, Melinda [3 ]
Pariser, David M. [4 ,5 ]
Simpson, Eric L. [6 ]
Etoh, Takafumi [7 ]
Chen, Zhen [8 ]
Sierka, Debra [9 ]
Shumel, Brad [8 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] SKiN Ctr Dermatol, Peterborough, ON, Canada
[4] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[5] Virginia Clin Res Inc, Norfolk, VA USA
[6] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[7] Tokyo Teishin Postal Serv Agcy Hosp, Tokyo, Japan
[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[9] Sanofi Genzyme, Cambridge, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
26839
引用
收藏
页码：AB118 / AB118
页数：1
相关论文
共 50 条
  • [21] Sleep is significantly improved by dupilumab in adults with moderate-to-severe atopic dermatitis: results of the DUPISTAD study
    Merola, J. F.
    Chiou, A. S.
    During, E.
    Costanzo, A.
    Foley, P.
    Ardeleanu, M.
    Liu, M.
    Ozturk, Z. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E156 - E156
  • [22] Dupilumab significantly improves sleep disturbance in adults with moderate-to-severe atopic dermatitis: Results of the DUPISTAD study
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB46 - AB46
  • [23] Dupilumab treatment for up to 100 weeks demonstrates sustained improvement in quality of life in adult patients with moderate-to-severe atopic dermatitis (LIBERTY AD OLE)
    Thaci, D.
    Deleuran, M.
    De Bruin-Weller, M.
    Chen, Z.
    Tomondy, P.
    Ardeleanu, M.
    Boklage, S.
    Shumel, B.
    Surendranathan, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 12 - 13
  • [24] TRALOKINUMAB IN COMBINATION WITH AS-NEEDED TOPICAL CORTICOSTEROIDS PROVIDES SUSTAINED IMPROVEMENTS IN ITCH AND SLEEP IN MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Elewski, Boni E.
    Stander, Sonja
    Zirwas, Matthew
    Silvestre, Juan Francisco
    Kalia, Sunil
    Gutermuth, Jan
    Mark, Thomas
    Tindberg, Ann-Marie
    Silverberg, Jonathan I.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 64 - 64
  • [25] Rapid and sustained improvement in skin pain with abrocitinib in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Thyssen, J. P.
    Bewley, A.
    Stander, S.
    Kim, B.
    Biswas, P.
    DiBonaventura, M.
    Watkins, M.
    Alderfer, J.
    Guler, E.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E150 - E151
  • [26] Dupilumab provides long-term efficacy over 2.5 years in adults with moderate-to-severe atopic dermatitis
    Cork, Michael
    Beck, Lisa
    Bissonnette, Robert
    Wollenberg, Andreas
    Simpson, Eric
    Praestgaard, Amy
    Aamodt, Kimberly
    Rossi, Ana
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 69 - 69
  • [27] Dupilumab provides sustained improvement of sleep disturbance in children ≥6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A. S.
    Wollenberg, A.
    Simpson, E. L.
    Beck, L. A.
    Chih-ho, Hong H.
    Marcoux, D.
    Bastian, M.
    Chen, Z.
    Levit, N. A.
    Bansal, A.
    Rossi, A. B.
    Chao, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 97 - 98
  • [28] Dupilumab with concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: A randomised, placebo-controlled phase 3 clinical trial (CHRONOS)
    Blauvelt, A.
    Gooderham, M.
    Foley, P.
    Griffiths, C. E. M.
    Cather, J. C.
    de Bruin-Weller, M.
    Zhu, X.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 55 - 55
  • [29] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal
    Thomson, J.
    Wernham, A. G. H.
    Williams, H. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (04) : 897 - 902
  • [30] Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis
    Elewski, B. E.
    Staender, S.
    Zirwas, M.
    Silvestre, J. F.
    Kalia, S.
    Gutermuth, J.
    Mark, T.
    Tindberg, A. M.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E83 - E84
12345